Nanobiomaterial-based vaccination immunotherapy of cancer
2021 · Biomaterials · 149 citations
https://doi.org/10.1016/j.biomaterials.2021.120709
T
Tianliang Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
2.0K
Citations
24
h-index
33
i10-index
Tianliang Li is an academic researcher from Shanghai University. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Advanced Nanomaterials in Catalysis & Nanoparticle-Based Drug Delivery. The author has an h-index of 24, co-authored 48 publications.
ORCID: 0000-0002-0736-7783Papers by this author
worksAcid‐Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer
2022 · Advanced Materials · 110 citations
https://doi.org/10.1002/adma.202209910
Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer
2020 · Nano Today · 72 citations
https://doi.org/10.1016/j.nantod.2020.101025
Metabolism/Immunity Dual‐Regulation Thermogels Potentiating Immunotherapy of Glioblastoma Through Lactate‐Excretion Inhibition and PD‐1/PD‐L1 Blockade
2024 · Advanced Science · 42 citations
https://doi.org/10.1002/advs.202310163
Surface-engineered nanobubbles with pH-/light-responsive drug release and charge-switchable behaviors for active NIR/MR/US imaging-guided tumor therapy
2018 · NPG Asia Materials · 33 citations
https://doi.org/10.1038/s41427-018-0094-6
Experimental study on the properties of a polymer-modified superfine cementitious composite material for waterproofing and plugging
2023 · Case Studies in Construction Materials · 17 citations
https://doi.org/10.1016/j.cscm.2023.e02552
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat